Fighting Fit

Drug giants face fines over generics

Drug companies should be punished by the EU if they delay production of cheaper versions of their medicines, says report

EU says drug industry delay tactics cost us €3bn

Consumers and taxpayers lose out as large pharmaceutical companies try to block production of cheaper drugs, EU says

Assura turnover up 60% on GP services growth

UK’s biggest private owner of GP surgeries will make loss this year but business growing on polyclinics trend

ImmuPharma soars after drug deal

Shares rose by 33% after company signed agreement with a US biopharmaceutical company that could be worth as much as $500m

SSL profits up as Durex sales rise

Company says brands are beating downturn as pre-tax profit for the six months to September 30 rose by 46% to £32.5m

UK redundancies reach 25,000 in just a week

BAE Systems, Rolls-Royce, AstraZeneca and Sony Ericsson were among the latest companies to reduce their headcounts

AstraZeneca suffers double setback

Pharma giant faces a generic challenge to its asthma treatment and has recorded disappointing trials for lung cancer drug

Over 4,000 British jobs face axe

In less than 12 hours, Virgin Media, Yell, GSK, Psion and Taylor Wimpey announce cuts in their workforce in a black day for British jobs

The way to fund NHS top-ups

Firms race to offer policies after u-turn on NHS cancer treatment

GSK cuts sales force as marketing model changes

The world’s second-biggest drugs company is following the lead of rivals and cutting 1,000 jobs from its US sales force